Articles
- As part of the National Agency for Pharmaceutical Products' commitment to strengthening the regulatory system and ensuring patients' access to safe, quality health products, the Agency's Director General, Dr Chérif DELIH, delivered a presentation entitled "Strengthening the principle of regulatory reliance to ensure the quality and availability of health products" during the African Ministerial Conference on the local production of medicines, held from 27 to 29 November 2025 in Algiers. The presentation highlights the importance of adopting the principle of regulatory reliance as a modern and effective mechanism that helps to: shorten registration timelines; improve the availability of medicines and health products; make better use of the Agency's resources; strengthen product control and vigilance; facilitate the export of locally manufactured products; and build the confidence of patients and professionals in the national system. The World Health Organization frames this principle through six core principles that ensure its effectiveness and affirm the preservation of national sovereignty: universality, national sovereignty, transparency, adherence to the legal framework, consistency and efficiency. The National Agency for Pharmaceutical Products stresses that regulatory reliance in no way means delegating its powers or relinquishing its regulatory sovereignty; it is a modern strategic approach that draws on the scientific expertise, assessments and decisions issued by internationally recognised regulatory authorities, in order to strengthen the quality and effectiveness of decision-making within our Agency.
Related articles
-
Signing of an Algerian-Russian Memorandum of Understanding to Enhance Cooperation in Pharmaceutical Inspection and Good Manufacturing Practices (GMP)
-
Strengthening Algerian-Egyptian Cooperation in the Pharmaceutical Sector
-
Inauguration of the regional annex of the National Agency of Pharmaceutical Products in Constantine and signing of a Memorandum of Understanding to strengthen research and innovation in the pharmaceutical industry